A novel glycine site-specific N-methyl- d-aspartate receptor antagonist prevents activation of the NMDA/NO/CGMP pathway by ammonia
Intrastriatal administration of ammonium ions (“ammonia”) via a microdialysis probe overactivates N-methyl- d-aspartate (NMDA) receptors, which results in cGMP accumulation in the microdialysates. Co-administration of a potent glycine site-specific NMDA receptor antagonist CGP 78608 ([(1 S)-1-[[(7-b...
Saved in:
Published in | Brain research Vol. 1015; no. 1; pp. 186 - 188 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
London
Elsevier B.V
23.07.2004
Amsterdam Elsevier New York, NY |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Intrastriatal administration of ammonium ions (“ammonia”) via a microdialysis probe overactivates
N-methyl-
d-aspartate (NMDA) receptors, which results in cGMP accumulation in the microdialysates. Co-administration of a potent glycine site-specific NMDA receptor antagonist CGP 78608 ([(1
S)-1-[[(7-bromo-1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl]amino]ethyl]phosphonate) significantly reduced (at 20 nM) or abolished (at 100 nM) ammonia-dependent cGMP synthesis. Since NMDA receptor activation is an important causative factor in ammonia neurotoxicity, the present results suggest the glycine site of the receptor to be a potential valuable target for protective intervention. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0006-8993 1872-6240 |
DOI: | 10.1016/j.brainres.2004.05.014 |